Visaka Industries Limited (NSE:VISAKAIND)

Regulus Therapeutics Revenue

In the fiscal year ending March 31, 2025, Visaka Industries had annual revenue of 15.43B INR with 1.09% growth. Visaka Industries had revenue of 4.26B in the quarter ending March 31, 2025, with 7.53% growth.

• Revenue: 15.43B
• Revenue Growth: +1.09%
• P/S Ratio: 0.48
• Revenue / Employee: 8.25M
• Employees: 1,871
• Market Cap: 7.38B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	15.43B	166.89M	1.09%
Mar 31, 2024	15.27B	-1.27B	-7.67%
Mar 31, 2023	16.53B	2.38B	16.78%
Mar 31, 2022	14.16B	2.69B	23.49%
Mar 31, 2021	11.47B	961.55M	9.15%